The average success rate of all ph2 trials is about a third, as of 2016 according to Wikipedia. It's the toughest one. I think ph3 success rate is closer to 80%
So while there will likely be tentative investors waiting for that to happen before buying in, with how BOT has structured their trials, a successful ph2 acne should substantially improve confidence that the rest of the products will be successful.
The average success rate of all ph2 trials is about a third, as...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $456.7M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 29.0¢ | 26.5¢ | $2.495M | 8.946M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36146 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1716192 | 5 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
29.0¢ |
Change
0.020 ( 5.30 %) |
||||
| Open | High | Low | Volume | ||
| 27.3¢ | 29.0¢ | 26.5¢ | 3951622 | ||
| Last updated 15.57pm 08/05/2024 ? | |||||
| BOT (ASX) Chart |